<

 
Data updated 2025-04-30 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date22753953.3 (espacenet)  (Federated)  (European Patent Register), 20220715
Patent/reg. no. and dateDK/EP 4370116, 20250115
Publication date20240522
Priority no. and dateUS 202163203333 P, 20210716, US 202263299753 P, 20220114, US 202263305609 P, 20220201, US 202263331197 P, 20220414, US 202263343975 P, 20220519
EP pub. no. and date EP 4370116 20240522
Effective date
Applicant/ownerCytokinetics, Inc., 350 Oyster Point Blvd
South San Francisco CA 94080, US
Applicant ref. no.V486600DK00
InventorMALIK, Fady,
San Francisco, California 94080, US,
KUPFER, Stuart,
San Francisco, California 94080, US,
HEITNER, Stephen B.,
San Francisco, California 94080, US,
ROBERTSON, Laura Ann,
San Francisco, California 94080, US,
MENG, Lixin,
San Francisco, California 94080, US,
OSMUKHINA, Anna,
San Francisco, California 94080, US,
WOHLTMAN, Qi,
San Francisco, California 94080, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/4245 (2006.01) , A61K 31/4402 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 9/00 (2006.01) 
TitleAFICAMTEN-DOSERINGSREGIMER TIL BEHANDLING AF OBSTRUKTIV HYPERTROFISK KARDIOMYOPATI
Int. application no.US2022073808
Int. publication no.WO2023288324
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact